Hester Biosciences has reported results for third quarter ended December 31, 2016.
The company has reported 21.85% rise in its net profit at Rs 5.80 crore for the quarter under review as compared to Rs 4.76 crore for the same quarter in the previous year. Total income from operation of the company increased by 17.95% at Rs 28.52 crore for Q3FY17 as compared Rs 24.18 crore for the corresponding quarter previous year.
Hester Biosciences is one of India’s leading animal healthcare companies and second largest poultry vaccine manufacturer. Located near Ahmedabad, Gujarat, Hester has a state-of-the-art manufacturing facility for products ranging from vaccines, health products to diagnostics. Hester’s services include seroprofiling for poultry flocks and mastitis control programs for cattle.
